Comparative Pharmacology
Head-to-head clinical analysis: IBUPROFEN AND FAMOTIDINE versus INDICLOR.
Peer-Reviewed Evidence
Head-to-head clinical analysis: IBUPROFEN AND FAMOTIDINE versus INDICLOR.
IBUPROFEN AND FAMOTIDINE vs INDICLOR
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX-1 and COX-2) enzymes, reducing prostaglandin synthesis, which decreases inflammation, pain, and fever. Famotidine is a histamine H2-receptor antagonist that inhibits gastric acid secretion by blocking histamine at H2 receptors on gastric parietal cells.
Alkylating agent that crosslinks DNA, inhibiting DNA replication and transcription.
One tablet (ibuprofen 800 mg/famotidine 26.6 mg) orally three times daily.
INDICLOR is not a recognized drug; no standard dosing available.
None Documented
None Documented
Ibuprofen: Terminal half-life 2-4 hours (normal renal function); prolonged to 3-6 hours in elderly or hepatic impairment. Famotidine: Terminal half-life 2.5-3.5 hours (normal renal function); extended to >20 hours in severe renal impairment (CrCl <10 mL/min).
Terminal elimination half-life is 12 hours (range 10-15 hours) in patients with normal renal function; prolonged in renal impairment (up to 25 hours in severe cases).
Ibuprofen: Renal excretion of metabolites (90%) and unchanged drug (<10%); biliary/fecal (minor). Famotidine: Renal excretion of unchanged drug (65-70%); metabolites (25-30%); biliary/fecal (minor).
Primarily renal excretion (approximately 70% unchanged drug); biliary/fecal excretion accounts for about 10-15% as metabolites.
Category D/X
Category C
NSAID
NSAID